Heidelberg Pharma AG (ETR:HPHA) | Finanzwire

Basculer en Français

11244	Companies
249580	Keywords
177708	Articles
135395	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 08/26/2026 at 18:35, 2 months 2 days ago

Heidelberg Pharma AG Granted Approval for Clinical Trial in China

Heidelberg Pharma Multiple Myeloma HDP-101 Trial Clinical Trial Approval Huadong Medicine
PRESS RELEASE

published on 08/26/2026 at 18:30, 2 months 2 days ago

Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Heidelberg Pharma AG and Huadong Medicine receive NMPA approval for Phase Ib/II clinical trial of HDP-101 combination therapy in China. Evaluation of BCMA-targeting ADC in patients with multiple myeloma

NMPA Approval Clinical Trial Heidelberg Pharma Huadong Medicine ADC Therapy
BRIEF

published on 07/15/2026 at 07:16, 3 months 14 days ago

Heidelberg Pharma Reports Positive First Half-Year of 2026

Financial Report Heidelberg Pharma AG Pamlectabart Tismanitin First Half-Year 2026 Phase IIa Clinical Trials
PRESS RELEASE

published on 07/15/2026 at 07:11, 3 months 14 days ago

Heidelberg Pharma Reports on First Half-Year 2026 and the Positive Course of Business
Heidelberg Pharma AG reports positive first half-year 2026 results, reaching milestones in clinical development and financial stability

Clinical Development Milestones Financial Stability Heidelberg Pharma AG First Half-Year
BRIEF

published on 06/23/2026 at 15:44, 4 months 5 days ago

Heidelberg Pharma's Annual General Meeting 2026 Overview

Annual General Meeting Shareholder Approval Supervisory Board Heidelberg Pharma Antibody Drug Conjugates
PRESS RELEASE

published on 06/23/2026 at 15:39, 4 months 5 days ago

Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2026
Heidelberg Pharma AG reports on the results of the Ordinary Annual General Meeting 2026, including approval of agenda items and election of new Supervisory Board member

Annual General Meeting Supervisory Board Biotech Heidelberg Pharma AG Ordinary AGM
BRIEF

published on 04/29/2026 at 07:10, 6 months ago

Heidelberg Pharma AG Reports Progress in Q1 2026

Financial Results Clinical Trials Heidelberg Pharma HDP-101 Biotech Development
PRESS RELEASE

published on 04/29/2026 at 07:05, 6 months ago

Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2026
Heidelberg Pharma AG reports significant progress in the first quarter of 2026 financially and in clinical development, completion of Phase I clinical trial, milestone payments triggered, and extended cash reach

Clinical Development Phase I Trial Heidelberg Pharma AG Milestone Payments Financial Progress
BRIEF

published on 04/17/2026 at 09:43, 6 months 11 days ago

Heidelberg Pharma Announces Executive Board Change

CFO Appointment Biotech Clinical Trial Heidelberg Pharma Executive Change
PRESS RELEASE

published on 04/17/2026 at 09:38, 6 months 11 days ago

Heidelberg Pharma Announces Change in Executive Board
Heidelberg Pharma announces change in Executive Board as CFO Walter Miller departs end of April, Peter Willinger appointed as new CFO from 1 May 2026. Company specializes in developing Antibody Drug Conjugates (ADCs)

CFO Executive Board Heidelberg Pharma Antibody Drug Conjugates ADCs

Accesswire

Published on 10/29/2026 at 08:00, 1 hour 32 minutes ago

Touchstone Exploration Provides an Operational Update
Published on 10/29/2026 at 07:30, 2 hours 2 minutes ago

Tocvan Pilot Mine Trench at Gran Pilar Averages 4.6 g/t Au With Samples Up to 24.4 g/t Au; New Zone 1.3 km East Returns Up to 234 g/t Ag
Published on 10/28/2026 at 22:35, 10 hours 57 minutes ago

Route1 Announces Third Quarter and Year to Date 2026 Financial Results Notification
Published on 10/28/2026 at 12:30, 21 hours 2 minutes ago

Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th
Published on 10/28/2026 at 12:30, 21 hours 2 minutes ago

AI/ML Innovations Announces Advance Notice Provisions

View all ACCESSWIRE

EQS Group

Published on 10/29/2026 at 09:26, 5 minutes ago

GFT and Itaú Unibanco Build AI-Based Solution to Accelerate the Bank’s Migration of Systems to the Cloud
Published on 10/29/2026 at 09:26, 5 minutes ago

FORTEC publishes its 2025/2026 consolidated financial statements and comes in slightly above forecast – positive EBIT expected for 2026/2027
Published on 10/29/2026 at 09:00, 31 minutes ago

Municipality Finance issues a USD 50 million tap under its MTN programme
Published on 10/29/2026 at 09:00, 31 minutes ago

Original-Research: ATOSS Software SE (von NuWays AG): BUY
Published on 10/29/2026 at 09:00, 31 minutes ago

Original-Research: 123fahrschule SE (von NuWays AG): BUY

Les Echos

Published on 10/29/2026 at 07:20, 2 hours 12 minutes ago

Q3 2026: Air Liquide accelerates, driven by sales growth and the launch of its strategic plan
Published on 10/29/2026 at 06:55, 2 hours 37 minutes ago

Recticel in higher gear
Published on 10/28/2026 at 18:09, 15 hours 22 minutes ago

Share buyback mandate
Published on 10/28/2026 at 17:45, 15 hours 47 minutes ago

VOGO obtains FIBA (International Basketball Federation) Approval for its Instant Replay System.
Published on 10/28/2026 at 17:45, 15 hours 47 minutes ago

Successful issue of a € 6.0 billion bond as part of the financing of the PTC acquisition

View all LES ECHOS COMFI WIRE